International Conference on Chemical Biology and Drug Design

This track will explore recent breakthroughs in chemical biology, focusing on innovative methodologies and technologies. Discussions will include the integration of chemical and biological approaches to understand complex biological systems.

This session will delve into the intricate mechanisms of enzyme action and their catalytic properties. Participants will examine the latest research on enzyme kinetics, structure-function relationships, and applications in drug design.

This track will focus on the principles and applications of molecular recognition in biological systems. Topics will include the study of protein-ligand interactions and the design of chemical probes for probing biomolecular interactions.

This session will highlight the role of medicinal chemistry in the discovery and development of new therapeutic agents. Presentations will cover structure-activity relationships, lead optimization, and the design of bioactive molecules.

This track will discuss the design and application of chemical probes to investigate therapeutic targets. Emphasis will be placed on the role of chemical biology in elucidating the mechanisms of action of potential drug candidates.

This session will explore the use of molecular docking and computational techniques in drug discovery. Participants will discuss advancements in predictive modeling and virtual screening methodologies.

This track will examine the intersection of chemical genetics and functional genomics in understanding gene function. Presentations will focus on the use of small molecules to probe biological pathways and cellular processes.

This session will cover the pharmacological aspects of drug development, including pharmacokinetics and pharmacodynamics. Discussions will focus on the translation of chemical biology findings into clinical applications.

This track will highlight the contributions of bioorganic chemistry to the field of drug discovery. Topics will include the design of novel organic compounds and their biological evaluation.

This session will focus on the development of molecular therapeutics aimed at specific disease targets. Participants will discuss innovative strategies for targeted drug delivery and therapeutic intervention.

This track will explore the chemical modulation of biomolecular interactions and its implications for drug design. Presentations will highlight strategies for enhancing or inhibiting molecular interactions to achieve therapeutic outcomes.